课题基金 / 基金详情

International Herpesvirus Workshop

International Herpesvirus Workshop
国际疱疹病毒研讨会
批准号:
8386850
负责人:
JAY A NELSON
金额:
$0.6万
依托单位国家:
美国
项目类别:
财政年份:
2012
资助国家:
美国
项目状态:
已结题
起止时间:
2012-06-01 至 2013-05-31

项目摘要

项目成果

JAY A NELSON的其他基金

相关文献

中文摘要
翻译
描述(由申请人提供):该提案要求提供资金用于支持博士后研究员和研究生参加 2012 年在加拿大艾伯塔省卡尔加里举行的第 37 届国际疱疹病毒研讨会 (IHW) 的旅费和注册费。IHW 是研究所有疱疹病毒的科学家的主要年度会议,已举办了 37 年。这次会议非常成功,部分原因在于世界领先的疱疹病毒研究人员的热情参与。研讨会的优势在于不同疱疹病毒比较、关键问题的不同方法的比较以及该领域领先研究人员的支持和参与,最重要的是包括有前途的年轻研究人员和接受培训的学生的支持和参与。此外,该论坛是真正的国际性论坛,全世界都有广泛的参加者。目前公认的八种人类疱疹病毒引起的多种疾病清楚地表明了这次会议的医学重要性。这些疾病包括皮肤和眼睛溃疡 (HSV-1)、生殖器病变 (HSV-2)、脑膜炎和脑炎(HSV-1 和 HSV-2)、传染性单核细胞增多症 (EBV)、水痘和带状疱疹 (VZV)。 CMV是先天性传播导致智力低下、失明和耳聋等出生缺陷的主要原因,也是艾滋病患者和器官移植受者的重要机会病原体。最近,CMV 被认为是动脉粥样硬化发展的致病因素。癌症也与疱疹病毒感染有关。 EBV 与伯基特淋巴瘤、其他 B 细胞肿瘤和鼻咽癌有关。最近发现的人类疱疹病毒(HHV-8 或 KSHV)与艾滋病患者和其他免疫抑制者以及其他群体的卡波西肉瘤有关。所有疱疹病毒都会终生存在,因此在免疫受损个体的治疗中造成重大问题。由大多数人类疱疹病毒重新激活引起的疾病是各种免疫患者群体发病和死亡的重要原因。研讨会将采用跨学科方法讨论以下主题:病毒结构、病毒进入和细胞间传播的机制、膜蛋白、发病机制和潜伏期、DNA复制、疫苗接种和免疫反应、转录控制、基因表达调节、化疗靶点和病毒基因治疗。 公共卫生相关性:国际疱疹病毒研讨会是疱疹病毒研究人员的首要科学会议,也是唯一一次跨学科关注疱疹病毒所有主要亚科以及从分子生物学到临床研究的各个方面的会议。
英文摘要
Description (as provided by the applicant): This proposal requests funds to be used to support travel and registration fees for postdoctoral fellows and graduate students to attend the 37th International Herpesvirus Workshop (IHW) in Calgary, Alberta, Canada, in 2012. The IHW is the major annual meeting for scientists studying all the herpesviruses and is very well-established in its 37th year. This meeting has been very successful, in part, because of the enthusiastic participation of the world's leading herpesvirus researchers. The strength of the Workshop rests on the cross-fertilization that results from comparison of different herpesviruses, different approaches to key questions and on the support and participation of leading researchers in the field, most significantly including promising young investigators and students in training. Moreover, the forum is truly international, with broad-based world-wide attendance. The medical importance of this meeting is clearly indicated from the wide variety of diseases caused by the now recognized eight human herpesviruses. These include skin and eye ulcerations (HSV-1), genital lesions (HSV-2), meningitis and encephalitis (HSV-1 and HSV-2), infectious mononucleosis (EBV), chicken pox and shingles (VZV). CMV is a major cause of birth defects including mental retardation, blindness and deafness due to congenital transmission but also a significant opportunistic pathogen in AIDS patients and organ transplant recipients. More recently, CMV has been implicated as pathogenic contributors in the development of atherosclerosis. Cancer has also been associated with herpesvirus infections. EBV is associated with Burkitt's lymphoma, other B cell neoplasias and nasopharyngeal carcinoma. The most recent human herpesvirus discovered (HHV-8 or KSHV) is associated with Kaposi's sarcoma in AIDS patients and other immunosuppressed persons and in other groups. All of the herpesviruses persist for life and therefore pose significant problems in the treatment of immune compromised individuals. Diseases caused by reactivation of most human herpesviruses are a significant cause of morbidity and mortality in various immune patient populations. Workshop sessions will take an interdisciplinary approach to the following topics: virus structure, mechanism of virus entry and cell-cell spread, membrane proteins, pathogenesis and latency, DNA replication, vaccination and the immune response, transcriptional control, regulation of gene expression, chemotherapeutic targets, and virus gene therapy. Public Health Relevance: The International Herpesvirus Workshop is the premier scientific meeting for herpesvirus researchers, and the only meeting with an interdisciplinary focus on all the major subfamilies of herpesviruses and all aspects of research from molecular biology to clinical studies.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
International Herpesvirus Workshop
The Administrative Core
Human Cytomegalovirus dysregulation of host hematopoietic progenitor cell signaling pathways to modulate latency and reactivation